Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT.

Hansmann G, Koestenberger M, Alastalo TP, Apitz C, Austin ED, Bonnet D, Budts W, D'Alto M, Gatzoulis MA, Hasan BS, Kozlik-Feldmann R, Kumar RK, Lammers AE, Latus H, Michel-Behnke I, Miera O, Morrell NW, Pieles G, Quandt D, Sallmon H, Schranz D, Tran-Lundmark K, Tulloh RMR, Warnecke G, Wåhlander H, Weber SC, Zartner P.

J Heart Lung Transplant. 2019 Sep;38(9):879-901. doi: 10.1016/j.healun.2019.06.022. Epub 2019 Jun 21.

PMID:
31495407
2.

Surgical Repair of Tetralogy of Fallot With Absent Pulmonary Valve: Favorable Long-Term Results.

Dorobantu DM, Stoicescu C, Tulloh RM, Stoica SC.

Semin Thorac Cardiovasc Surg. 2019 May 29. pii: S1043-0679(19)30166-2. doi: 10.1053/j.semtcvs.2019.05.022. [Epub ahead of print]

PMID:
31150827
3.

Surgical versus balloon valvotomy in neonates and infants: results from the UK National Audit.

Dorobantu DM, Taliotis D, Tulloh RM, Sharabiani MTA, Mohamed Ahmed E, Angelini GD, Stoica SC.

Open Heart. 2019 Feb 14;6(1):e000938. doi: 10.1136/openhrt-2018-000938. eCollection 2019.

4.

Assessment of Myocardial Function in Kenyan Children With Severe, Acute Malnutrition: The Cardiac Physiology in Malnutrition (CAPMAL) Study.

Brent B, Obonyo N, Akech S, Shebbe M, Mpoya A, Mturi N, Berkley JA, Tulloh RMR, Maitland K.

JAMA Netw Open. 2019 Mar 1;2(3):e191054. doi: 10.1001/jamanetworkopen.2019.1054.

5.

ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension.

Grünig E, Eichstaedt C, Barberà JA, Benjamin N, Blanco I, Bossone E, Cittadini A, Coghlan G, Corris P, D'Alto M, D'Andrea A, Delcroix M, de Man F, Gaine S, Ghio S, Gibbs S, Gumbiene L, Howard LS, Johnson M, Jurevičienė E, Kiely DG, Kovacs G, MacKenzie A, Marra AM, McCaffrey N, McCaughey P, Naeije R, Olschewski H, Pepke-Zaba J, Reis A, Santos M, Saxer S, Tulloh RM, Ulrich S, Vonk Noordegraaf A, Peacock AJ.

Eur Respir J. 2019 Feb 28;53(2). pii: 1800332. doi: 10.1183/13993003.00332-2018. Print 2019 Feb.

PMID:
30578391
6.

Echocardiographic Screening for Pulmonary Hypertension in Congenital Heart Disease: JACC Review Topic of the Week.

Dimopoulos K, Condliffe R, Tulloh RMR, Clift P, Alonso-Gonzalez R, Bedair R, Chung NAY, Coghlan G, Fitzsimmons S, Frigiola A, Howard LS, Jenkins P, Kenny D, Li W, MacDonald ST, McCabe C, Oliver JJ, Spence MS, Szantho GV, von Klemperer K, Wilson DG, Wort SJ; CHAMPION Steering Committee.

J Am Coll Cardiol. 2018 Dec 4;72(22):2778-2788. doi: 10.1016/j.jacc.2018.08.2201.

7.

Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015.

Tulloh RMR, Mayon-White R, Harnden A, Ramanan AV, Tizard EJ, Shingadia D, Michie CA, Lynn RM, Levin M, Franklin OD, Craggs P, Davidson S, Stirzaker R, Danson M, Brogan PA.

Arch Dis Child. 2019 Jul;104(7):640-646. doi: 10.1136/archdischild-2018-315087. Epub 2018 Aug 13.

PMID:
30104394
8.

Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease.

Condliffe R, Clift P, Dimopoulos K, Tulloh RMR.

Pulm Circ. 2018 Jul-Sep;8(3):2045894018792501. doi: 10.1177/2045894018792501. Epub 2018 Jul 23.

9.

Respiratory virus prophylaxis in congenital heart disease.

Joshi M, Tulloh RM.

Future Cardiol. 2018 Sep;14(5):417-425. doi: 10.2217/fca-2017-0096. Epub 2018 Jun 7. Review.

PMID:
29877720
10.

A pilot randomised controlled trial investigating a mindfulness-based stress reduction (MBSR) intervention in individuals with pulmonary arterial hypertension (PAH): the PATHWAYS study.

Tulloh RMR, Garratt V, Tagney J, Turner-Cobb J, Marques E, Greenwood R, Howard L, Gin-Sing W, Barton A, Ewings P, Craggs P, Hollingworth W.

Pilot Feasibility Stud. 2018 May 21;4:78. doi: 10.1186/s40814-018-0270-z. eCollection 2018.

11.

Pulmonary hypertension in congenital heart disease.

Pascall E, Tulloh RM.

Future Cardiol. 2018 Jul;14(4):343-353. doi: 10.2217/fca-2017-0065. Epub 2018 May 24. Review.

12.

Primary repair versus surgical and transcatheter palliation in infants with tetralogy of Fallot.

Dorobantu DM, Mahani AS, Sharabiani MTA, Pandey R, Angelini GD, Parry AJ, Tulloh RMR, Martin RP, Stoica SC.

Heart. 2018 Nov;104(22):1864-1870. doi: 10.1136/heartjnl-2018-312958. Epub 2018 May 2.

13.

The cardiac proteome in patients with congenital ventricular septal defect: A comparative study between right atria and right ventricles.

Bond AR, Iacobazzi D, Abdul-Ghani S, Ghorbel MT, Heesom KJ, George SJ, Caputo M, Suleiman MS, Tulloh RM.

J Proteomics. 2019 Jan 16;191:107-113. doi: 10.1016/j.jprot.2018.03.022. Epub 2018 Mar 20.

14.

Lung Function, Inflammation, and Endothelin-1 in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.

Low A, George S, Howard L, Bell N, Millar A, Tulloh RMR.

J Am Heart Assoc. 2018 Feb 14;7(4). pii: e007249. doi: 10.1161/JAHA.117.007249.

15.

Changes in contractile protein expression are linked to ventricular stiffness in infants with pulmonary hypertension or right ventricular hypertrophy due to congenital heart disease.

Bond AR, Iacobazzi D, Abdul-Ghani S, Ghorbel M, Heesom K, Wilson M, Gillett C, George SJ, Caputo M, Suleiman S, Tulloh RMR.

Open Heart. 2018 Jan 3;5(1):e000716. doi: 10.1136/openhrt-2017-000716. eCollection 2018.

16.

Retrospective study of the impact of unrecognised Kawasaki disease, coronary aneurysm and ectasia.

Waterhouse BR, Tulloh RMR, Kim Y, Creasy W, Adlam D, Johnson TW.

Int J Cardiol. 2017 Dec 1;248:308-313. doi: 10.1016/j.ijcard.2017.08.018. Epub 2017 Aug 10.

PMID:
28818354
17.

CHD and respiratory syncytial virus: global expert exchange recommendations.

Tulloh RMR, Medrano-Lopez C, Checchia PA, Stapper C, Sumitomo N, Gorenflo M, Jung Bae E, Juanico A, Gil-Jaurena JM, Wu MH, Farha T, Dodge-Khatami A, Tsang R, Notario G, Wegzyn C.

Cardiol Young. 2017 Oct;27(8):1504-1521. doi: 10.1017/S1047951117000609. Epub 2017 Jun 16.

PMID:
28619123
18.

Early Experience of Macitentan for Pulmonary Arterial Hypertension in Adult Congenital Heart Disease.

Herbert S, Gin-Sing W, Howard L, Tulloh RMR.

Heart Lung Circ. 2017 Oct;26(10):1113-1116. doi: 10.1016/j.hlc.2016.12.011. Epub 2017 Feb 6.

PMID:
28237536
19.

Corticosteroids for the treatment of Kawasaki disease in children.

Wardle AJ, Connolly GM, Seager MJ, Tulloh RM.

Cochrane Database Syst Rev. 2017 Jan 27;1:CD011188. doi: 10.1002/14651858.CD011188.pub2. Review.

20.

The incidence of Kawasaki disease after vaccination within the UK pre-school National Immunisation Programme: an observational THIN database study.

Hall GC, Tulloh RM, Tulloh LE.

Pharmacoepidemiol Drug Saf. 2016 Nov;25(11):1331-1336. doi: 10.1002/pds.4108. Epub 2016 Sep 21.

PMID:
27651105
21.

Guanylate cyclase stimulators for pulmonary hypertension.

Wardle AJ, Seager MJ, Wardle R, Tulloh RM, Gibbs JS.

Cochrane Database Syst Rev. 2016 Aug 2;(8):CD011205. doi: 10.1002/14651858.CD011205.pub2. Review.

PMID:
27482837
22.

Kawasaki disease incidence in children and adolescents: an observational study in primary care.

Hall GC, Tulloh LE, Tulloh RM.

Br J Gen Pract. 2016 Apr;66(645):e271-6. doi: 10.3399/bjgp16X684325. Epub 2016 Feb 23.

23.

Cellular and molecular basis of RV hypertrophy in congenital heart disease.

Iacobazzi D, Suleiman MS, Ghorbel M, George SJ, Caputo M, Tulloh RM.

Heart. 2016 Jan;102(1):12-7. doi: 10.1136/heartjnl-2015-308348. Epub 2015 Oct 29. Review.

24.

Cardiovascular status after Kawasaki disease in the UK.

Shah V, Christov G, Mukasa T, Brogan KS, Wade A, Eleftheriou D, Levin M, Tulloh RM, Almeida B, Dillon MJ, Marek J, Klein N, Brogan PA.

Heart. 2015 Oct;101(20):1646-55. doi: 10.1136/heartjnl-2015-307734. Epub 2015 Aug 27.

25.

Anomalous Left Coronary From the Pulmonary Artery Presenting as Ventricular Fibrillation After Persistent Ductus Arteriosus Ligation.

Fudulu DP, Tulloh RM, Wolf AR, Parry AJ, Stoica SC.

Ann Thorac Surg. 2015 Jul;100(1):e9-e10. doi: 10.1016/j.athoracsur.2015.04.015.

PMID:
26140805
26.

Lung function in pulmonary hypertension.

Low AT, Medford AR, Millar AB, Tulloh RM.

Respir Med. 2015 Oct;109(10):1244-9. doi: 10.1016/j.rmed.2015.05.022. Epub 2015 May 27. Review.

27.

Pulmonary arterial hypertension exacerbated by ruxolitinib.

Low AT, Howard L, Harrison C, Tulloh RM.

Haematologica. 2015 Jun;100(6):e244-5. doi: 10.3324/haematol.2014.120816. Epub 2015 Feb 14. No abstract available.

28.

Prevention and prophylaxis of respiratory syncytial virus in pediatric cardiology: a UK perspective.

Tulloh RM, Bury S.

Future Cardiol. 2014 Mar;10(2):235-42. doi: 10.2217/fca.14.4. Review.

PMID:
24762251
29.

Comparison of the effect of inhaled anaesthetic with intravenous anaesthetic on pulmonary vascular resistance measurement during cardiac catheterisation.

Giesen LA, White M, Tulloh RM.

Cardiol Young. 2015 Feb;25(2):368-72. doi: 10.1017/S1047951114000195. Epub 2014 Feb 19.

PMID:
24548796
30.

Adaptations of aortic and pulmonary artery flow parameters measured by phase-contrast magnetic resonance angiography during supine aerobic exercise.

Pieles GE, Szantho G, Rodrigues JC, Lawton CB, Stuart AG, Bucciarelli-Ducci C, Turner MS, Williams CA, Tulloh RM, Hamilton MC.

Eur J Appl Physiol. 2014 May;114(5):1013-23. doi: 10.1007/s00421-014-2833-x. Epub 2014 Feb 7.

PMID:
24504653
31.

Paediatric pulmonary hypertension and sildenafil: current practice and controversies.

Wardle AJ, Tulloh RM.

Arch Dis Child Educ Pract Ed. 2013 Aug;98(4):141-7. doi: 10.1136/archdischild-2013-303981. Epub 2013 Jun 15.

PMID:
23771819
32.

Evolving management of pediatric pulmonary arterial hypertension: impact of phosphodiesterase inhibitors.

Wardle AJ, Tulloh RM.

Pediatr Cardiol. 2013 Feb;34(2):213-9. doi: 10.1007/s00246-012-0598-8. Epub 2012 Dec 19. Review.

PMID:
23250648
33.

Atrial septal defect closure with an Amplatzer septal occluder fenestrated with a coronary stent in a child with pulmonary arterial hypertension.

Skinner GJ, Tulloh RM, Tometzki AJ, Schulze-Neick I, Morgan GJ.

Cardiol Young. 2013 Oct;23(5):692-6. doi: 10.1017/S1047951112001771. Epub 2012 Oct 23.

PMID:
23089055
34.

The sinister course of an intramural right coronary artery.

Yim DL, Hamilton MC, Tulloh RM.

Cardiol Young. 2012 Apr;22(2):206-8. doi: 10.1017/S104795111100103X. Epub 2011 Jul 19.

PMID:
21771384
35.

A randomized controlled trial of motavizumab versus palivizumab for the prophylaxis of serious respiratory syncytial virus disease in children with hemodynamically significant congenital heart disease.

Feltes TF, Sondheimer HM, Tulloh RM, Harris BS, Jensen KM, Losonsky GA, Griffin MP; Motavizumab Cardiac Study Group.

Pediatr Res. 2011 Aug;70(2):186-91. doi: 10.1203/PDR.0b013e318220a553.

PMID:
21522037
36.

Management of pulmonary hypertension in Down syndrome.

Hawkins A, Langton-Hewer S, Henderson J, Tulloh RM.

Eur J Pediatr. 2011 Jul;170(7):915-21. doi: 10.1007/s00431-010-1378-1. Epub 2011 Jan 4.

PMID:
21203772
37.

Invited commentary.

Parry AJ, Tulloh RM.

Ann Thorac Surg. 2011 Jan;91(1):186-7. doi: 10.1016/j.athoracsur.2010.08.040. No abstract available.

PMID:
21172510
38.

PDA and pulmonary hypertension: should the duct be ligated?

McCulloch VA, Tulloh RM.

Arch Dis Child Fetal Neonatal Ed. 2010 Jan;95(1):F75. doi: 10.1136/adc.2009.161786. No abstract available.

PMID:
20019203
39.

Kawasaki disease in children.

Wood LE, Tulloh RM.

Heart. 2009 May;95(10):787-92. doi: 10.1136/hrt.2008.143669. Epub 2008 Aug 12. Review.

PMID:
18697808
40.

Takayasu's disease: a review.

Tann OR, Tulloh RM, Hamilton MC.

Cardiol Young. 2008 Jun;18(3):250-9. doi: 10.1017/S1047951108002060. Epub 2008 Mar 7. Review.

PMID:
18325145
41.

Antenatal diagnosis and postnatal treatment of intrapulmonary arteriovenous malformation.

Kenny DP, Tsai-Goodman B, Martin RP, Tulloh RM.

Arch Dis Child Fetal Neonatal Ed. 2007 Sep;92(5):F366. No abstract available.

42.

Congenital heart disease in relation to pulmonary hypertension in paediatric practice.

Tulloh RM.

Paediatr Respir Rev. 2005 Sep;6(3):174-80. Review.

PMID:
16153566
44.

Coronary artery changes in patients with Kawasaki disease.

Tulloh RM, Wood LE.

Acta Paediatr Suppl. 2004 Dec;93(446):75-9. Review.

PMID:
15702674
45.

Interventional cardiac catheterisation in congenital heart disease.

Andrews RE, Tulloh RM.

Arch Dis Child. 2004 Dec;89(12):1168-73. Review.

46.

Acute myocardial infarction as a cause of death in palliated hypoplastic left heart syndrome.

Andrews RE, Tulloh RM, Anderson DR, Lucas SB.

Heart. 2004 Apr;90(4):e17.

47.

An echocardiographic study of tetralogy of Fallot in the fetus and infant.

Pepas LP, Savis A, Jones A, Sharland GK, Tulloh RM, Simpson JM.

Cardiol Young. 2003 Jun;13(3):240-7.

PMID:
12903870
48.

Percutaneous retrieval of central venous catheter fragments.

Andrews RE, Tulloh RM, Rigby ML.

Arch Dis Child. 2002 Aug;87(2):149-50.

49.

Coil occlusion of systemic venous collaterals in hypoplastic left heart syndrome.

Andrews RE, Tulloh RM, Anderson DR.

Heart. 2002 Aug;88(2):167-9.

50.

Coronary arterial complications before and after the arterial switch operation: is the future clear?

Tzifa A, Tulloh RM.

Cardiol Young. 2002 Mar;12(2):164-71. Review. No abstract available.

PMID:
12018722

Supplemental Content

Loading ...
Support Center